高级检索

妊娠期糖尿病孕妇肠道菌群与临床代谢表型的关联性研究进展

Research progress on the association between gut microbiota and clinical metabolic phenotype among pregnant women with gestational diabetes mellitus

  • 摘要: 人体的肠道内存在丰富的微生物,其肠道菌群丰度及多样性改变与糖尿病的发生发展密切相关。妊娠期糖代谢异常的孕妇往往合并肠道菌群紊乱。通过加强孕期管理,调控相关“特征性菌株”与“菌群组成结构”,改善孕妇肠道微生态是优化临床干预方案的潜在路径。妊娠期糖尿病(gestational diabetes mellitus,GDM)的临床代谢表型具有充分的多样性,往往会合并各种代谢异常(高血脂、肥胖等)。单一的暴露因素分析(妊娠期高血糖)难以全面阐述肠道微生态异常的驱动机制。本文对近些年来国内外有关GDM孕妇代谢表型异常与肠道菌群特征关联性的研究进行综述,以期为探索GDM干预策略提供新的依据。

     

    Abstract: Human gut is home to a large number of microorganisms, and changes in the diversity and richness of the gut microbiota are directly linked to the occurrence and development of diabetes. Disorders of the gut microbiota are common in pregnant women who have impaired glucose metabolism. Improving the intestinal microecology of pregnant women by controlling the pertinent “characteristic strains” and “microflora composition structure” is a feasible strategy to optimize clinical intervention programs through strengthening pregnancy management. There are several different clinical metabolic phenotypes of gestational diabetes mellitus (GDM), and they are frequently accompanied by other metabolic disorders (such as obesity and hyperlipidemia). It is challenging to properly understand the underlying mechanism of intestine microecological abnormalities from a single exposure factor analysis (hyperglycemia during pregnancy). In this article, recent researches on the association between metabolic phenotypic anomalies and gut microbiota characteristics among pregnant women with GDM were reviewed, with the goal of providing new evidence for the exploration of GDM intervention strategies.

     

/

返回文章
返回